Bellevue Life Sciences Acquisition Corp.
BLAC
Revenue
0.00
0.000.00%
-Assets
20.63M
▼-16.64M▼-44.64%
3 Months ChangeLiabilities
5.49M
▲673.05k▲13.98%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0001193125-24-244725
2024-10-22
Form 8-K
ID: 0001193125-24-241077
2024-10-15
Form 8-K
ID: 0001193125-24-237600
2024-10-10
Form 8-K
ID: 0001193125-24-235955
2024-10-10
Form 8-K
ID: 0001193125-24-235949
2024-09-24
Form 8-K
ID: 0001193125-24-224807
2024-09-16
Form 8-K
ID: 0001193125-24-219608
2024-08-22
Form 8-K
ID: 0001193125-24-205378
2024-08-19
Form 10-Q
ID: 0001193125-24-202828
2024-08-16
Form 8-K
ID: 0001193125-24-202145